Paolo Pucci's Net Worth
$34.6 Million
Who is Paolo Pucci?
Paolo Pucci has an estimated net worth of $34.6 Million. This is based on reported shares across multiple companies, which include WEST PHARMACEUTICAL SERVICES INC, Merus N.V., Replimune Group, Inc., Trillium Therapeutics Inc., NEWLINK GENETICS CORP, DYAX CORP, and ARQULE INC.
SEC CIK
Paolo Pucci's CIK is 0001436861
Past Insider Trading and Trends
2017 was Paolo Pucci's most active year for acquiring shares with 10 total transactions. Paolo Pucci's most active month to acquire stocks was the month of April. 2020 was Paolo Pucci's most active year for disposing of shares, totalling 14 transactions. Paolo Pucci's most active month to dispose stocks was the month of December. 2019 saw Paolo Pucci paying a total of $5,825,907.40 for 2,179,912 shares, this is the most they've acquired in one year. In 2020 Paolo Pucci cashed out on 4,340,637 shares for a total of $24,715,640.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WEST PHARMACEUTICAL SERVICES INC (WST) Snapshot price: $297.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.06% | 564 |
—
|
—
| 9.88K |
Apr 23
| |||
Form 4
| +7.08% | 616 |
—
|
—
| 9.31K |
Apr 25
| |||
Form 4
| +7.84% | 632 |
—
|
—
| 8.7K |
May 24
| |||
Form 4
| +7.71% | 577 |
—
|
—
| 8.06K |
May 4
| |||
Form 4
| +15.01% | 975 |
—
|
—
| 7.47K |
May 5
| |||
Form 4
| +32.59% | 1.56K |
—
|
—
| 6.37K |
May 7
| |||
Form 4
| +61.25% | 1.82K |
—
|
—
| 4.8K |
May 1
| |||
Form 4
| +132.46% | 1.7K |
—
|
—
| 2.98K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
∞
| 1.28K |
—
|
—
| 1.28K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merus N.V. (MRUS) Snapshot price: $50
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trillium Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEWLINK GENETICS CORP (LUMO) Snapshot price: $3.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||